Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH). (2021)

First Author: Brennan PN
Attributed to:  Autologous Macrophage Therapy for Liver Cirrhosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-053190

PubMed Identifier: 34750149

Publication URI: http://europepmc.org/abstract/MED/34750149

Type: Journal Article/Review

Volume: 11

Parent Publication: BMJ open

Issue: 11

ISSN: 2044-6055